Skip to main content

Market Overview

Morning Market Losers

Share:

Sunshine Heart Inc. (NASDAQ: SSH) shares dipped 26.73% to $3.92 on suspension of C-Pulse study and report of patient deaths.

BioLineRx, Ltd. (NASDAQ: BLRX) fell 23.13% to $2.16 after the company priced $25 million underwritten public offering of its American Depositary Shares.

WuXi PharmaTech (Cayman) Inc. (NYSE: WX) shares slipped 16.63% to $34.15. WuXi Pharma reported Q4 earnings of $0.46 per share on revenue of $190.7 million. The company expected FY15 adjusted earnings of $1.73 to $1.78 per share on revenue of $790 million to $800 million.

Checkpoint Systems Inc. (NYSE: CKP) shares dropped 14.82% to $11.44. Checkpoint Systems reported Q4 earnings of $0.26 per share on revenue of $183.11 million and issued a weak FY15 outlook.

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares fell 9.56% to $5.96. The company said in a Thursday filing that its Chief Medical Officer Gary C. Burgess resigned.

Violin Memory Inc (NYSE: VMEM) declined 8.52% to $3.65. Violin Memory reported a Q4 loss $0.19 per share on revenue of $20.5 million.

Emergent BioSolutions, Inc. (NYSE: EBS) dropped 8.24% to $26.83 after the company posted quarterly results and said it is investigating contamination of product at a manufacturing operation.

Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares slipped 7.67% to $7.40 on reports that the company could face fines, penalties over early release of data.

Lululemon Athletica Inc. (NASDAQ: LULU) shares fell 5.73% to $61.13. Goldman Sachs downgraded Lululemon Athletica from Neutral to Sell.

 

Related Articles (BLRX + SSH)

View Comments and Join the Discussion!

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com